Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis
نویسندگان
چکیده
منابع مشابه
Idiopathic venous thrombosis. Long-term anticoagulant therapy? No.
Venous thrombosis is a chronic disease with a recurrence rate of approximately 30% within 5-8 years. The optimal duration of secondary thromboprophylaxis in these patients entails balancing the risk of recurrence against the risk of treatment-associated bleeding. There is agreement that patients with a first idiopathic venous thrombosis should receive vitamin K antagonists for at least 3-6 mont...
متن کاملIdiopathic venous thrombosis
Idiopathic venous thromboembolism has been shown to be associated with a high frequency of recurrence. Therefore, the most important aim of long-term treatment is secondary prevention. It has also been shown that long-term anticoagulation with vitamin K antagonists can impressively reduce the rate of recurrence. However, this effect was only maintained during anticoagulation and disappeared aft...
متن کاملIdiopathic venous thrombosis
Idiopathic venous thromboembolism has been shown to be associated with a high frequency of recurrence. Therefore, the most important aim of long-term treatment is secondary prevention. It has also been shown that long-term anticoagulation with vitamin K antagonists can impressively reduce the rate of recurrence. However, this effect was only maintained during anticoagulation and disappeared aft...
متن کاملOral anticoagulant therapies: balancing the risks.
PURPOSE To describe the mechanisms of action, pharmacokinetics, and rate of bleeding complications from warfarin and target-specific oral anticoagulants; methods for assessing the risk for thromboembolism and bleeding in patients receiving oral anticoagulants or temporarily interrupting such therapy to undergo elective invasive procedures or surgery; therapeutic strategies for balancing these r...
متن کاملBalancing risks and benefits of oral contraception.
We publish in this issue an authoritative and timely opinion on the effects of third-generation oral contraceptives on the incidence of venous thromboembolism (VTE) and acute myocardial infarction (AMI) among users (Spitzer, 1997). The author is a highly experienced and leading epidemiologist in the field, and his conclusions are disturbing. He details what seems to be serious misinterpretation...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thrombosis and Haemostasis
سال: 2009
ISSN: 1538-7933,1538-7836
DOI: 10.1111/j.1538-7836.2009.03388.x